|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-9-27
|
|
pubmed:abstractText |
The purpose of this study was to assess the effectiveness of azimilide, a class III antiarrhythmic drug, in reducing the frequency of symptomatic arrhythmia recurrences in patients with atrial fibrillation, atrial flutter or both.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
794-802
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10987602-Aged,
pubmed-meshheading:10987602-Anti-Arrhythmia Agents,
pubmed-meshheading:10987602-Atrial Fibrillation,
pubmed-meshheading:10987602-Atrial Flutter,
pubmed-meshheading:10987602-Dose-Response Relationship, Drug,
pubmed-meshheading:10987602-Electrocardiography,
pubmed-meshheading:10987602-Female,
pubmed-meshheading:10987602-Heart Rate,
pubmed-meshheading:10987602-Humans,
pubmed-meshheading:10987602-Imidazoles,
pubmed-meshheading:10987602-Imidazolidines,
pubmed-meshheading:10987602-Male,
pubmed-meshheading:10987602-Middle Aged,
pubmed-meshheading:10987602-Piperazines,
pubmed-meshheading:10987602-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.
|
|
pubmed:affiliation |
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. ed.pritchett@duke.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
